RPID

Healthcare Medical Devices

Rapid Micro Biosystems, Inc.

$0.94
-0.02 -1.77% today

Price History

Not enough data

Key Stats

Market Cap
47.30M
Avg Volume
270,380
EPS
-$1.11
52W High
$4.94
52W Low
$0.86
Div. Yield
0.0%

Analyst Ratings

Buy
0
Str Buy
5
Buy
0
Hold
0
Sell
0
Str Sell

Valuation

Forward P/E
-1.32
P/B Ratio
2.66
P/S Ratio
1.34
EV/EBITDA
-1.07
EV/Revenue
1.43

Margins

Gross Margin 5.5%
Operating Margin (153.0%)
Net Margin (145.6%)
EBITDA Margin (133.8%)

Growth & Returns

Revenue Growth (YoY)
10.9%
Return on Equity
(141.6%)
Return on Assets
(46.4%)

Liquidity & Leverage

Current Ratio
2.55
Quick Ratio
1.43
Debt / Equity
1.32
Total Cash
20.50M
Total Debt
23.48M

About

Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, biologics, medical devices, and personal care products in the United States, Switzerland, Germany, Japan, and internationally. The company offers Growth Direct platform, which includes growth direct system, proprietary consumables, lab information management system connection software, and customer support and validation services. Its platform automates and modernizes the antiquated, manual microbial quality control (MQC), testing workflows for therapeutic modalities, such as biologics and cell and gene therapies, vaccines, and sterile injectables. The company also provides onsite technical training services. Its solutions are used in environmental monitoring, water, bioburden, and sterility release testing applications. In addition, the company offers RMBNucleus Mold Alarm software; and Growth Direct LIMS connection software. Rapid Micro Biosystems, Inc. was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. The company was incorporated in 2006 and is headquartered in Lexington, Massachusetts.

www.rapidmicrobio.com